In vitro diagnostics (IVD) is the technique in which medical devices and reagents are used to examine specimens such as blood, urine, stool, tissues and other body fluids, which are derived from the human body to detect diseases, conditions and infections. The tests can be performed in stand-alone laboratory, hospital based laboratory and point of care. Some of the significant technologies incorporated in vitro diagnostics include polymerase chain reaction (PCR), microarray techniques, sequencing technology and mass spectrometry, which are used for test sample preparation. Incessant innovations in IVD product design and technology have encouraged doctors and researchers to shift their focus from traditional diagnostic methods to personalized medicines.
The world in vitro diagnostics market is estimated to garner $81.3 billion by 2022, registering a CAGR of 4.9% over the forecast period. Growing need of IVD testing arises due to increasing incidences of chronic and infectious diseases and growing geriatric population prone to immunological disorders. Moreover, increased application of personalised medicines and widespread knowledge of rare diseases are boosting the growth of IVD market. In addition, increasing incidences of colorectal cancer, neurological disorders, gynaecological diseases and others would boost the adoption of IVD devices and reagents. On the contrary, stringent government regulations and unfavourable reimbursement policies would limit the growth of the market. The rising demand for technologically advanced diagnostic devices and increased disposable income of consumers provides huge growth potential for IVD market.
The report segments the market across different categories such as product type, techniques, application, end users and geography. Based on product types, the market is segmented into reagents, instruments, and services & software. Based on techniques, the market is segmented into immunodiagnostics, blood testing, molecular diagnostics, tissue diagnostics, clinical chemistry and other clinical techniques. Similarly, based on indication, the market is further segmented into, infectious diseases, cancer, cardiac diseases, immune system disorders, nephrological diseases, gastrointestinal disorders and other indications. Based on end users, the market is categorised into standalone laboratory, hospitals academics & medical schools and others. The geographical breakdown and detailed analysis of each of the aforesaid segments are included for North America, Europe, Asia-Pacific and LAMEA.
Companies are adopting acquisition and partnership as key development strategies in this market Roche diagnostics, Abbott, Danaher Corporation are few of the dominant players in the IVD market. Other companies include Johnson and Johnson, Sysmex Corporation, Becton Dickinson, bioMrieux, Thermo Fisher Scientific, Inc., Ortho-Clinical Diagnostics, Siemens AGand Alere Inc. The comprehensive competitive analysis and profiles of major market players mentioned above are profiled in the report.
KEY BENEFITS FOR STAKEHOLDERS:
IVD MARKET KEY SEGMENTS:
Table of Contents
CHAPTER 1 INTRODUCTION
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO perspective
2.2 Market beyond: what to expect by 2027
2.2.1 Base case scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario
CHAPTER 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key findings
3.2.1 Top impacting factors
3.2.2 Top investment pockets
3.2.3 Top winning strategies
3.3 Porter five forces analysis
3.3.1 Bargaining power of supplier
3.3.2 Bargaining power of buyers
3.3.3 Low threat of new entrants
3.3.4 Threat of substitute
3.3.5 Competitive rivalry
3.4 Government regulations
3.5 Value chain analysis
3.6 Case studies
3.6.1 Case Study 1: Positioning of new IVD Platform by Life Science
3.6.2 Case Study 2: To enhance the operational capabilities of diagnostic chemistry system
3.7 Research & Analysis
3.7.1 Clinical Trials of research studies conducted for IVD market
3.8 Significant Progressions in IVD technologies
3.8.1 Total Laboratory Automation (TLA)
3.8.2 Evolving markets in digital pathology
3.8.3 Omics and Genetics tests in IVD
3.8.4 Point-of-Care testing
3.8.5 Emerging technologies diagnostics and influence on IVD
3.9 Market dynamics
3.9.1 Drivers
3.9.1.1 Increasing incidences of chronic and infectious diseases
3.9.1.2 Technological advancements in IVD
3.9.1.3 Emergence of minimal invasive technologies
3.9.1.4 Increasing government expenditures on healthcare
3.9.1.5 Increase in popularity personalized medicine approach
3.9.2 Restraints
3.9.2.1 Unclear reimbursement policies
3.9.2.2 Stringent Regulatory policies
3.9.3 Opportunities
3.9.3.1 Potential Opportunities for outsourcing
3.9.3.2 Convergence of new Technologies.
CHAPTER 4 WORLD IVD MARKET, BY PRODUCT TYPE, 2014-2022
4.1 Overview
4.1.1 Market size and forecast
4.2 Reagents
4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.3 Instruments
4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast
4.4 Software and services
4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast
CHAPTER 5 WORLD IVD MARKET, BY TECHNIQUES, 2014-2022
5.1 Immunodiagnostics
5.1.1 Key market trends
5.1.2 Key growth factors and opportunities
5.1.3 Market size and forecast
5.2 Blood testing
5.2.1 Key market trends
5.2.2 Key growth factors and opportunities
5.2.3 Market size and forecast
5.3 Molecular diagnostics
5.3.1 Key market trends
5.3.2 Key growth factors and opportunities
5.3.3 Market size and forecast
5.4 Tissue diagnostics
5.4.1 Key market trends
5.4.2 Key growth factors and opportunities
5.4.3 Market size and forecast
5.5 Clinical chemistry
5.5.1 Key market trends
5.5.2 Key growth factors and opportunities
5.5.3 Market size and forecast
5.6 Other clinical techniques
5.6.1 Key market trends
5.6.2 Key growth factors and opportunities
5.6.3 Market size and forecast
CHAPTER 6 WORLD IVD MARKET, BY APPLICATION, 2014-2022
6.1 Infectious diseases
6.1.1 Key market trends
6.1.2 Key growth factors and opportunities
6.1.3 Market size and forecast
6.2 Cancer
6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast
6.3 Cardiac diseases
6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast
6.4 Immune system diseases
6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast
6.5 Nephrological diseases
6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast
6.6 Gastrointestinal diseases
6.6.1 Key market trends
6.6.2 Key growth factors and opportunities
6.6.3 Market size and forecast
6.7 Other indications
6.7.1 Key market trends
6.7.2Key growth factors and opportunities
6.7.3Market size and forecast
CHAPTER 7 WORLD IVD MARKET BY END USERS, 2014-2022
7.1 Standalone laboratories
7.1.1 Market size and forecast
7.2 Hospitals
7.2.1 Key market trends
7.2.2 Key growth factors and opportunities
7.2.3 Market size and forecast
7.3 Academic and medical schools
7.3.1 Key market trends
7.3.2 Key growth factors and opportunities
7.3.3 Market size and forecast
7.4 Others
7.4.1 Key market trends
7.4.2 Key growth factors and opportunities
7.4.3 Market size and forecast
CHAPTER 8 WORLD IVD MARKET BY GEOGRAPHY, 2014-2022
8.1 North America
8.1.1 Key market trends
8.1.2 Key growth factors and opportunities
8.1.3 Market size and forecast
8.1.4 United states
8.1.4.1 Market size and forecast
8.1.5 Canada
8.1.5.1 Market size and forecast
8.1.6 Mexico
8.1.6.1 Market size and forecast
8.2 Europe
8.2.1 Key market trends
8.2.2 Key growth factors and opportunities
8.2.3 Market size and forecast
8.2.4 Germany
8.2.4.1 Market size and forecast
8.2.5 France
8.2.5.1 Market size and forecast
8.2.6 United Kingdom
8.2.6.1 Market size and forecast
8.2.7 Others
8.2.7.1 Market size and forecast
8.3 Asia Pacific
8.3.1 Key market trends
8.3.2 Key growth factors and opportunities
8.3.3 Market size and forecast
8.3.4 India
8.3.4.1 Market size and forecast
8.3.5 China
8.3.5.1 Market size and forecast
8.3.6 Japan
8.3.6.1 Market size and forecast
8.3.7 Australia
8.3.7.1 Market size and forecast
8.3.8 Others
8.3.8.1 Market size and forecast
8.4 LAMEA
8.4.1 Key market trends
8.4.2 Key growth factors and opportunities
8.4.3 Market size and forecast
8.4.4 Latin America
8.4.4.1 Market size and forecast
8.4.5 Middle East
8.4.5.1 Market size and forecast
8.4.6 Africa
8.4.6.1 Market size and forecast
CHAPTER 9 COMPANY PROFILES
9.1 Affymetrix Inc.
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Financial performance of Affymetrix Inc.
9.1.4 Key Strategies and development
9.1.5 SWOT analysis of Affymetrix
9.2 Alere Inc.
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Business performance
9.2.4 Key strategies and developments
9.2.5 SWOT analysis of Alere
9.3 Biomerieux
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Business performance
9.3.4 Key strategies and developments
9.3.5 SWOT analysis of BioMerieux
9.4 Danaher Corporation.
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Business performance
9.4.4 Key strategies and development
9.4.5 SWOT analysis of Danaher Corporation
9.5 Roche Diagnostics
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Business performance
9.5.4 Key strategies and developments
9.5.5 SWOT analysis of Roche Diagnostics
9.6 Becton Dickinson and Company
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Business performance
9.6.4 Key strategies and development
9.6.5 SWOT analysis of Becton Dickinson and Company
9.7 Bio-Rad Laboratories, Inc.
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Business performance
9.7.4 Key strategies and developments
9.7.5 SWOT analysis of Bio-Rad Laboratories, Inc.
9.8 Abbott Laboratories
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Business performance
9.8.4 Key strategies and developments
9.8.5 SWOT analysis of Abbott Laboratories
9.9 Bayer AG.
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Business performance
9.9.4 Key strategies and development
9.9.5 SWOT analysis of Bayer AG
9.10 Arkray, Inc.
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Key strategies and development
9.10.4 SWOT analysis of Arkray, Inc.
9.11 Sysmex Corporation
9.11.1 Company overview
9.11.2 Company snapshot
9.11.3 Business performance
9.11.4 Key strategies and developments
9.11.5 SWOT analysis of Sysmex Corporation
9.12 Johnson & Johnson Pvt Ltd.
9.12.1 Company overview
9.12.2 Company snapshot
9.12.3 Business performance
9.12.4 Key strategies and development
9.12.5 SWOT analysis of Johnson & Johnson Pvt Ltd.
9.13 Siemens AG
9.13.1 Company overview
9.13.2 Company snapshot
9.13.3 Business performance
9.13.4 Key strategies and development
9.13.5 SWOT analysis of Siemens AG
List of Figures
FIG. 1 WORLD IVD MARKET SNAPSHOT
FIG. 1 TOP IMPACTING FACTORS, BASE CASE SCENARIO (2022-2027)
FIG. 2 TOP IMPACTING FACTORS, RAPID GROWTH SCENARIO (2022-2027)
FIG. 3 TOP IMPACTING FACTORS, DIMINISHING GROWTH SCENARIO (2022-2027)
FIG. 4 TOP IMPACTING FACTORS
FIG. 5 TOP INVESTMENT POCKETS OF IVD MARKET BY TECHNIQUES 2014-2022.
FIG. 6 TOP WINNING STRATEGIES
FIG. 7 TOP WINNING STRATEGIES
FIG. 8 VALUE CHAIN ANALYSIS FOR IVD MARKET
FIG. 9 KEY FINANCIALS OF AFFYMETRIX INC. REVENUE, 2012-2014, $MILLION
FIG. 10 KEY FINANCIALS OF AFFYMETRIX INC. REVENUE BY SEGMENTS
FIG. 11 KEY FINANCIALS OF AFFYMETRIX INC.CORPORATION REVENUE BY GEOGRAPHY
FIG. 12 SWOT ANALYSIS OF AFFYMETRIX INC.
FIG. 13 KEY FINANCIALS OF ALERE INC. REVENUE, 2012-2014, $MILLION
FIG. 14 ALERE INC., % NET SALES BY BUSINESS SEGMENTS, 2014
FIG. 15 ALERE INC., % NET SALES BY GEOGRAPHY, 2014
FIG. 16 SWOT ANALYSIS OF ALERE INC.
FIG. 17 KEY FINANCIALS OF BIOMERIEUX REVENUE, 2011-2014, $MILLION
FIG. 18 BIOMERIEUX, % NET SALES BY TECHNOLOGY, 2014
FIG. 19 BIOMERIEUX, % NET SALES BY GEOGRAPHY, 2014
FIG. 20 SWOT ANALYSIS OF BIOMERIEUX
FIG. 21 DANAHER CORPORATION, % NET SALES BY BUSINESS SEGMENT, 2014
FIG. 22 DANAHER CORPORATION, % NET SALES BY GEOGRAPHY, 2014
FIG. 23 SWOT ANALYSIS OF DANAHER CORPORATION
FIG. 24 KEY FINANCIALS OF ROCHE DIAGNOSTICS REVENUE, 2012-2014, $MILLION
FIG. 25 ROCHE DIAGNOSTICS, % NET SALES BY BUSINESS SEGMENT, 2014
FIG. 26 ROCHE DIAGNOSTICS, % NET SALES BY GEOGRAPHY, 2014
FIG. 27 SWOT ANALYSIS OF ROCHE DIAGNOSTICS
FIG. 28 KEY FINANCIALS OF BECTON, DICKINSON AND COMPANY REVENUE, 2011-2014, $MILLION
FIG. 29 KEY FINANCIALS OF BECTON DICKINSON AND COMPANY REVENUES BY SEGMENT 2014
FIG. 30 KEY FINANCIALS OF BECTON DICKINSON AND COMPANY SALES BY GEOGRAPHY 2014
FIG. 31 SWOT ANALYSIS OF BECTON DICKINSON AND COMPANY
FIG. 32 KEY FINANCIALS OF BIO-RAD LABORATORIES REVENUE, 2012-2014, $MILLION
FIG. 33 BIO RAD LABORATORIES, INC., % REVENUE BY BUSINESS SEGMENT, 2014
FIG. 34 BIO RAD LABORATORIES, INC., % REVENUE BY GEOGRAPHY, 2014
FIG. 35 SWOT ANALYSIS OF BIO-RAD LABORATORIES, INC.
FIG. 36 KEY FINANCIALS OF ABBOTT LABORATORIES REVENUE, 2012-2014, $MILLION
FIG. 37 ABBOTT LABORATORIES, INC., % REVENUE BY BUSINESS SEGMENT, 2014
FIG. 38 ABBOTT LABORATORIES, INC., % REVENUE BY GEOGRAPHY, 2014
FIG. 39 SWOT ANALYSIS OF ABBOTT LABORATORIES
FIG. 40 KEY FINANCIALS OF ABBOTT LABORATORIES REVENUE, 2012-2014, $MILLION
FIG. 41 BAYER AG, % REVENUE BY BUSINESS SEGMENT, 2014
FIG. 42 SWOT ANALYSIS OF BAYER AG
FIG. 43 SWOT ANALYSIS OF ARKRAY, INC.
FIG. 44 KEY FINANCIALS OF SYSMEX CORPORATION REVENUE, 2012-2014, $MILLION
FIG. 45 SYSMEX CORPORATION, % REVENUE, BY BUSINESS SEGMENT, 2014
FIG. 46 SYSMEX CORPORATION, % REVENUE, BY PRODUCT TYPE, 2014
FIG. 47 SYSMEX CORPORATION, % REVENUE BY GEOGRAPHY, (2014)
FIG. 48 SWOT ANALYSIS OF SYSMEX CORPORATION
FIG. 49 KEY FINANCIALS OF JOHNSON & JOHSNON $MILLION (2012-2014)
FIG. 50 FINANCIAL REVENUES BY SEGMENTS (2014)
FIG. 51 FINANCIAL REVENUES BY GEOGRAPHY (2014)
FIG. 52 SWOT ANALYSIS OF JOHNSON & JOHNSON PVT LTD.
FIG. 53
FIG. 54 SIEMENS AG., % REVENUE BY BUSINESS SEGMENT, 2014
FIG. 55 SIEMENS AG., % REVENUE BY GEOGRAPHY, 2014
FIG. 56 SWOT ANALYSIS OF SIEMENS AG
List of Table
TABLE 1 WORLD IVD BASE CASE SCENARIO MARKET, BY GEOGRAPHY, 2022 2027 ($MILLION)
TABLE 2 WORLD IVD RAPID GROWTH SCENARIO MARKET, BY GEOGRAPHY, 2022 2027 ($MILLION)
TABLE 3 WORLD IVD DIMINISHING GROWTH SCENARIO MARKET, BY GEOGRAPHY, 2022 2027 ($MILLION)
TABLE 4 PORTERS FIVE FORCES ANALYSIS
TABLE 5 CLINICAL TRIALS - IN VITRO DIAGNOSTIC DEVICES
TABLE 6 GLOBAL INCIDENCES OF DISEASES
TABLE 7 WORLD IVD MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 8 WORLD IVD REAGENTS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 9 WORLD IVD INSTRUMENTS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 10 WORLD IVD SOFTWARE AND SERVICES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 11 WORLD IVD MARKET BY TECHNIQUE, 2014-2022 ($MILLION)
TABLE 12 WORLD IVD IMMUNODIAGNOSTIC TECHNIQUE MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 13 WORLD IVD BLOOD TESTING TECHNIQUE MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 14 WORLD IVD MOLECULAR DIAGNOSTICS TECHNIQUE MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 15 WORLD IVD TISSUE DIAGNOSTICS TECHNIQUE MARKET, 2014-2022, ($MILLION)
TABLE 16 WORLD IVD CLINICAL CHEMISTRY TECHNIQUE MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 17 WORLD IVD OTHER CLINICAL TECHNIQUES MARKET, BY GEOGRAPHY, 2014-2022, ($MILLION)
TABLE 18 WORLD IVD MARKET, BY INDICATION, 2014-2022 ($MILLION)
TABLE 19 WORLD IVD INFECTIOUS DISEASES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 20 WORLD IVD CANCER MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 21 WORLD IVD CARDIAC DISEASES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 22 WORLD IVD IMMUNE SYSTEM DISORDER MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 23 WORLD IVD NEPHROLOGICAL DISEASES MARKET, BY GEOGRAPHY, 2014-2022, ($MILLION)
TABLE 24 WORLD IVD GASTRINTESTINAL DISEASES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 25 WORLD IVD OTHER INDICATION MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 26 WORLD IVD MARKET, BY END USER, 2014-2022, ($MILLION)
TABLE 27 WORLD IVD STANDALONE LABORATORIES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 28 WORLD IVD HOSPITALS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 29 WORLD IVD ACADEMIC AND MEDICAL SCHOOLS MARKET, BY GEOGRAPHY, 2014- 2022 ($MILLION)
TABLE 30 WORLD IVD OTHERS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 31 WORLD IVD MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 32 NORTH AMERICA IVD MARKET, BY TECHNIQUES, 2014-2022 ($MILLION)
TABLE 33 UNITED STATES IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)
TABLE 34 CANADA IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)
TABLE 35 MEXICO IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)
TABLE 36 EUROPE IVD MARKET, BY TECHNIQUES, 2014-2022 ($MILLION)
TABLE 37 GERMANY IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)
TABLE 38 FRANCE IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)
TABLE 39 UNITED KINGDOM IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)
TABLE 40 OTHERS EUROPEAN IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)
TABLE 41 ASIA PACIFIC IVD MARKET, BY TECHNIQUES, 2014-2022 ($MILLION)
TABLE 42 INDIA IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)
TABLE 43 CHINA IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)
TABLE 44 JAPAN IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)
TABLE 45 CATEGORIZATION OF IVD DEVICES
TABLE 46 AUSTRALIA IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)
TABLE 47 OTHERS IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)
TABLE 48 LAMEA IVD MARKET, BY TECHNIQUES, 2014-2022 ($MILLION)
TABLE 49 LATIN AMERICA IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)
TABLE 50 MIDDLE EAST IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)
TABLE 51 AFRICA IVD MARKET REVENUE, BY TECHNIQUES, 2014-2022, ($MILLION)
TABLE 52 COMPANY SNAPSHOT OF AFFYMETRIX INC.
TABLE 53 ALERE INC. COMPANY SNAPSHOT
TABLE 54 BIOMERIEUX COMPANY SNAPSHOT
TABLE 55 DANAHER CORPORATION COMPANY SNAPSHOT
TABLE 56 ROCHE DIAGNOSTICS COMPANY SNAPSHOT
TABLE 57 BECTON DICKINSON AND COMPANY SNAPSHOT
TABLE 58 BIO-RAD LABORATORIES, INC. COMAPNY SNAPSHOT
TABLE 59 ABBOTT LABORATORIES SNAPSHOT
TABLE 60 BAYER AG COMPANY SNAPSHOT
TABLE 61 ARKRAY, INC. COMPANY SNAPSHOT
TABLE 62 SYSMEX CORPORATION COMPANY SNAPSHOT
TABLE 63 JOHNSON & JOHNSON PVT LTD. COMPANY SNAPSHOT
TABLE 64 SIEMENS AGCOMPANY SNAPSHOT
Contact us at the Consulting WP office nearest to you or submit a business inquiry online.
Subscribe to Our Newsletter
Published On : November 2019
$ 3600
Published On : November 2019
$ 3600
Published On : November 2019
$ 3600
$ 3950
Published On : April 2019
$ 3000
